MedTrace Logo

Registry Study of Proton Radiotherapy in Lymphoma

NCT04613388 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-04-29

No results posted yet for this study

Summary

The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.

Conditions

  • Mediastinal Lymphoma

Interventions

OTHER

Assesment of Effectiveness and side effects

Case Report forms, Quality of life questionaire

Sponsors & Collaborators

  • University Hospital Heidelberg

    lead OTHER

Principal Investigators

  • Laila König, MD · University Hospital Heidelberg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2030-08-01
Completion
2031-08-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04613388 on ClinicalTrials.gov